Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial
Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now indicates that the study is no longer enrolling participants. New sections How to Read a Study Record, Common Questions, and How to Join a Study were added, the Intervention/Treatment label was updated, and the revision is now v3.6.0.SummaryDifference0.5%

- Check18 days agoChange DetectedRevision: v3.5.5 appears on the page, replacing the previous v3.5.4. This indicates a small platform update that does not change the study details or results presented.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now shows a new revision number (v3.5.4) in place of the previous v3.5.3, indicating a backend update; the study details and layout remain unchanged.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check69 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 for the study record. This appears to be a metadata update rather than a change to the core study content.SummaryDifference0.0%

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.